Sign in
CompletedNo phase

Health IT Generated PROs to Improve Outcomes in Cirrhosis

Key facts

Who runs it
Virginia Commonwealth University
Where
Richmond and Rochester, United StatesSee the 3 sites
Trial code
Status
Completed
People taking part
232 people enrolled
Started
22 Jun 2018
Ended
22 May 2024
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Health-IT +/- Scheduled Follow Up
Record updated
17 September 2025

Who can take part

Age
21 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (19)Hide the full registry criteria

Other criteria

  • Patient Inclusion Criteria:
  • Cirrhosis patients ≥21 years of age hospitalized for non-elective reasons
  • Adult caregiver and the patient living in the same house
  • Able to complete the Patient Buddy training and evaluation
  • Discharged home from the hospital
  • Discharge hospital as primary hospital base; Caregiver Inclusion Criteria:
  • Living in same dwelling as patient for the last ≥1 year
  • Able to complete the Patient Buddy training and evaluation
  • Familiar with the patient's routine; Patient Exclusion Criteria:
  • Elective hospitalization
  • Lack of an adult caregiver
  • Active substance abuse within 1 month of the hospitalization (alcohol use is acceptable provided the patient does not have alcoholic hepatitis during this admission or <1 month prior to admission)
  • Unable to perform training or give consent
  • Patients discharged to hospice, nursing home or extended care facilities
  • pregnant women
  • patients with limited English proficiency; Caregiver Exclusion Criteria
  • Unable or unwilling to train or adhere to study guidelines
  • Unfamiliar with the patient routines
  • Not in the same house as the patient

Where in United States

  • Hunter Holmes McGuire VA Medical CenterRichmond, United States
  • Virginia Commonwealth UniversityRichmond, United States
  • Mayo ClinicRochester, United States

About the trial

What the trial wants to find out

SPECIFIC AIM 1: To evaluate in a multi-center, randomized trial the effectiveness of PROs elicited using PatientBuddy and EncephalApp on the prevention of avoidable 30 day readmissions in patients with cirrhosis and their caregivers compared to standard of care.

The 2 groups in the trial

  • Control GroupNo study treatment, for comparison

    Standard of care counseling and discharge instructions per local hospital policy. Standard of care follow up phone calls and visits at baseline and at 30 days. Follow-up will be for 30 days

  • Health IT +/- Scheduled Follow UpTreatment being tested

    Subjects and caregivers will be given individual phones loaded with the Patient Buddy App and the EncephalApp that will be used to enter medications, issues and orientation questions daily. There will be messages and phone calls as needed per the App and visits will be at baseline, scheduled at 15 days and at 30 days. In addition, scheduled phone calls will be performed at days 7 and 21.Follow-up will be for 30 days

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
17 September 2025